• Home
• Company
• Manufacturing
• Product Catalogues
• Contacts

NZP Synthesis

DextraNZ.com is the new name for the nzpsynthesis.com web site. This rebranding was executed by New Zealand Pharmaceuticals Ltd (NZP) after the acquisition of Dextra Laboratories.

This web site aligns the product development, small molecule synthesis and GMP Pilot Plant capabilities at the Dextra premises, in Reading, England with the large-scale synthesis and other manufacturing capabilities at the New Zealand site.

Large scale manufacturing of selected Dextra products or large scale custom synthesis will be undertaken at the New Zealand site. This offers Dextra’s customers a low cost, regulated cGMP site for the efficient production of pharmaceutical starting materials and APIs.

NZP is a long established manufacturer of biochemicals and chemicals used as pharmaceutical intermediates, active pharmaceutical ingredients, and dietary supplements. NZP’s manufacturing skills accelerate business growth and profitability for companies in the pharmaceutical and biotechnology sectors.

Companies outsource their manufacturing to NZP because of its commitment to quality and excellent business relationships.

Through its synthesis capabilities, NZP & Dextra offer -

• Small molecule synthesis, especially derivatives of carbohydrates and bile acids
• Intermediates and APIs from kg to tonnes per annum scale.
• Synthetic modification of natural compounds for commercial development
• Process optimisation, qualification and documentation
• Analytical method development, qualification and documentation
• Long term niche manufacturing of pharmaceutical intermediates and APIs (GMP)
• CMC and Drug Master Files when required
• Botanical drug or dietary supplement production
• Efficient and cost effective manufacturing
• High quality business relationships.